FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/095402 [Registered on: 25/09/2025] Trial Registered Prospectively
Last Modified On: 24/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Other 
Public Title of Study   A study to see how weakness in patients with COPD affects their chances of survival and the number of days they stay in ICU 
Scientific Title of Study   Impact of Frailty Score on Predicting Mortality and Length of ICU Stay in COPD patients: A Prospective Observational Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
YEC-4/2025/078 version 02 11/08/2025  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Anjali Surendran K P 
Designation  Student 
Affiliation  Yenepoya School of Allied Health Sciences (Deemed to be University) 
Address  MSc in Respiratory Therapy (Student) Yenepoya School of Allied Health Sciences (Deemed to be University) Mudipu Campus, Near Surya Tech Park Kayargoli, Kurnad Post, Bantwal TQ.

Dakshina Kannada
KARNATAKA
574153
India 
Phone  7356100909  
Fax    
Email  anjalisurendrankp@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Kavya Shettigar K 
Designation  Assistant Professor 
Affiliation  Yenepoya School of Allied Health Sciences (Deemed to be University) 
Address  Guide, Department of Respiratory Therapy Yenepoya School of Allied Health Sciences (Deemed to be University) Mudipu Campus, Near Surya Tech Park Kayargoli, Kurnad Post, Bantwal TQ.

Dakshina Kannada
KARNATAKA
574153
India 
Phone  9741734428  
Fax    
Email  kavyashettigar@yenepoya.edu.in  
 
Details of Contact Person
Public Query
 
Name  Nivetha N 
Designation  Assistant Professor 
Affiliation  Yenepoya School of Allied Health Sciences (Deemed to be University) 
Address  Co Guide, Department of Respiratory Therapy Yenepoya School of Allied Health Sciences (Deemed to be University) Mudipu Campus, Near Surya Tech Park Kayargoli, Kurnad Post, Bantwal TQ.

Dakshina Kannada
KARNATAKA
574153
India 
Phone  9361113568  
Fax    
Email  nivethan@yenepoya.edu.in   
 
Source of Monetary or Material Support  
Yenepoya School of Allied Health Sciences (Deemed to be University) Mudipu Campus, Near Surya Tech Park Kayargoli, Kurnad Post, Bantwal TQ.  
 
Primary Sponsor  
Name  Anjali Surendran K P 
Address  Yenepoya School of Allied Health Sciences (Deemed to be University) Mudipu Campus, Near Surya Tech Park Kayargoli, Kurnad Post, Bantwal TQ.  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Anjali Surendran K P  Yenepoya Medical College Hospital  MICU and Stepdown ICU, 2nd floor, Yenepoya Medical College Hospital, University road, Derlakatte, Mangalore, 575018
Dakshina Kannada
KARNATAKA 
7356100909

anjalisurendrankp@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Yenepoya Ethics Committe-4  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J449||Chronic obstructive pulmonary disease, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Any gender of Age 40 years to 80 years.
Confirmed diagnosis of COPD.
ICU admission for acute exacerbation of COPD.
Patients shifted to another ICU within the same hospital.

 
 
ExclusionCriteria 
Details  Patients with other terminal illnesses.(Advanced or metastatic cancers,End-Stage Organ Failure, Severe Neurological Conditions with Poor Prognosis, Advanced Immunodeficiency Syndromes) Patients Shifted from the ICU within 24 hours.
Patients with incomplete medical records.
Patients shifted from the ICU to ward.
Patients readmitted to ICU from ward. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The length of the ICU stay can be assesed in relation to the frailty scoring.
 
At ICU discharge or 30 days after admission, 
 
Secondary Outcome  
Outcome  TimePoints 
Predictive accuracy of the frailty scoring can be assessed compared to APACHE II and SOFA score for ICU mortality in COPD patients.  At ICU discharge or 30 days after admission, 
 
Target Sample Size   Total Sample Size="81"
Sample Size from India="81" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  05/10/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary    This is a prospective observational study to be conducted in the Medical ICU and step down ICU of Yenepoya Medical College Hospital Mangalore . The study aims to evaluate the impact of frailty on outcomes in patients with Chronic Obstructive Pulmonary Disease admitted to the ICU. Frailty will be assessed  using the Clinical Frailty Scale and compared with standard severity scoring systems including APACHE II and SOFA. Adult patients with COPD admitted to the ICU during the study period will be consecutively enrolled after applying eligibility criteria. Demographic clinical and laboratory data will be obtained from medical records and patients will be followed until ICU discharge or up to 30 days. Mortality and length of ICU stay will be documented and statistical analysis will be performed to compare the predictive ability of frailty with APACHE II and SOFA scores. The study is self funded ethically approved does not involve any additional intervention beyond routine care and seeks to provide evidence to guide prognostication and resource planning for critically ill COPD patients. 
Close